The International Biophysics Corporation Afflovest is intended for promoting airway clearance and improvement of bronchial drainage by enhancing mobilization of bronchial secretions where external manipulation of the thorax is the physician’s choice of treatment.
With a physician’s prescription and guidance, patients can tailor AffloVest to their needs. Multiple settings allow for different intensity levels depending on the patient’s size and specific respiratory or chronic lung condition. The number of patients who may benefit from the innovative AffloVest treatments is considerable.
Below are some of the diseases and conditions in which physicians may prescribe HFCWO devices:
- Cystic Fibrosis
- Late Effects of poliomyelitis
- Other deficiencies of circulating enzymes
- Anterior horn cell diseases
- Multiple sclerosis
- Muscular dystrophy
- Myotonic disorders
- Disorders of the diaphragm